Patents by Inventor Polly Pine

Polly Pine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230173042
    Abstract: The invention relates to methods of treating diseases with L-asparaginase.
    Type: Application
    Filed: November 30, 2018
    Publication date: June 8, 2023
    Inventors: Polly PINE, Hemamalini GURSAHANI
  • Publication number: 20130274277
    Abstract: Compounds I and II as well as salts and pharmaceutical compositions containing them are useful for treating diseases and/or disorders of the skin, such as cutaneous lupus, for example acute cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, or discoid lupus erythematosus. In certain embodiments, the compounds are provided in topical compositions.
    Type: Application
    Filed: May 30, 2013
    Publication date: October 17, 2013
    Inventors: Daniel Magilavy, Polly Pine
  • Patent number: 8497279
    Abstract: Compounds I and II as well as salts and pharmaceutical compositions containing them are useful for treating diseases and/or disorders of the skin, such as cutaneous lupus, for example acute cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, or discoid lupus erythematosus. In certain embodiments, the compounds are provided in topical compositions.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: July 30, 2013
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Daniel Magilavy, Polly Pine
  • Publication number: 20120232106
    Abstract: Compounds I and II as well as salts and pharmaceutical compositions containing them are useful for treating diseases and/or disorders of the skin, such as cutaneous lupus, for example acute cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, or discoid lupus erythematosus. In certain embodiments, the compounds are provided in topical compositions.
    Type: Application
    Filed: March 9, 2012
    Publication date: September 13, 2012
    Inventors: Daniel Magilavy, Polly Pine
  • Patent number: 7576053
    Abstract: The present disclosure provides methods and compositions using Syk inhibitory compounds for treating degenerative bone disorders and as prophylactic treatment to prevent bone loss. These treatments may reduce the fracture risk associated with bone loss and compromised bone strength.
    Type: Grant
    Filed: June 13, 2006
    Date of Patent: August 18, 2009
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Polly Pine
  • Publication number: 20070004626
    Abstract: The present disclosure provides methods and compositions using Syk inhibitory compounds for treating degenerative bone disorders and as prophylactic treatment to prevent bone loss. These treatments may reduce the fracture risk associated with bone loss and compromised bone strength.
    Type: Application
    Filed: June 13, 2006
    Publication date: January 4, 2007
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Polly Pine